Bodyscan Corporation logo

Bodyscan Corporation (BDYS)

Market Closed
14 Aug, 20:00
OTC GREY OTC GREY
$
0. 00
0
0%
$
- Market Cap
- P/E Ratio
- Div Yield
18,500 Volume
- Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track BDYS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BDYS closed today higher at $0, an increase of 0% from yesterday's close, completing a monthly increase of 0% or $0. Over the past 12 months, BDYS stock lost -83.3333%.
BDYS is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

BDYS Chart

Bodyscan Corporation (BDYS) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Bodyscan Corporation is listed on OTC GREY.

What is its stock symbol?

The ticker symbol is BDYS.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Bodyscan Corporation ever had a stock split?

No, there has never been a stock split.

Bodyscan Corporation Profile

Consumer Finance Industry
Financials Sector
Jeffrey Volpe CEO
OTC GREY Exchange
09689P103 CUSIP
US Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Based in Irvine, California, BodyScan Corp. specializes in advanced medical imaging services. Its primary focus is on utilizing cutting-edge GE-Imatron Electron Beam Tomography (EBT) technology. This technology is instrumental in diagnosing a wide range of health conditions, including coronary artery disease (CAD), lung diseases, and the detection of tumors and stones within the body. The company's expertise in deploying this sophisticated imaging method offers a significant advantage in early and accurate disease detection, which is critical for effective treatment and management. BodyScan Corp. aims to provide high-quality medical imaging services that contribute to improved patient outcomes.

Products and Services

  • GE-Imatron Electron Beam Tomography (EBT) Scanning for Coronary Artery Disease (CAD)

    This premium imaging service focuses on the early detection of CAD, a leading cause of heart disease. By utilizing EBT, BodyScan Corp. can offer non-invasive, detailed images of the coronary arteries, enabling the early identification and management of potential heart health risks.

  • Lung Disease Detection

    BodyScan Corp. leverages the EBT technology to detect various lung diseases at an early stage. This service is crucial for patients at risk of lung conditions, providing them with accurate diagnoses and facilitating timely medical intervention.

  • Tumor Detection

    The use of EBT scanning by BodyScan Corp. extends to the identification and assessment of tumors. This technology allows for high-resolution images that help in determining the presence, size, and location of tumors, which is vital for planning appropriate treatment strategies.

  • Stones Detection

    BodyScan Corp.'s services also encompass the detection of stones in the body, such as kidney stones or gallstones. Through EBT scans, the company can identify and evaluate stones, aiding in the diagnosis and guiding the choice of treatment procedure for patients.

Contact Information

Address: 6 Venture Street
Phone: 949-794-8980